MedTrace Logo

AVEIR™ Leadless Pacemaker (LP) United Kingdom (UK) Registry

NCT06854484 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-07-29

No results posted yet for this study

Summary

This observational study will follow patients requiring implantation of leadless pacemaker for 5 years after implantation. The main goal is to evaluate the long term safety and efficacy of AVEIR™ leadless pacemaker device in the usual clinical settings within the UK National Health Service. In addition, the study will collect data to understand patient characteristics receiving this type of pacemaker.

Conditions

  • Bradycardia
  • Atrio-Ventricular Block
  • Syncope

Interventions

DEVICE

AVEIR™leadless pacemaker

AVEIR™ leadless pacemaker implantation

Sponsors & Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Tom Wong, MD · Royal Brompton and Harefield Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2032-03-31
Completion
2032-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06854484 on ClinicalTrials.gov